Blood testosterone

Measurement of testosterone: how important is a morning blood draw?

Objective: Since testosterone levels exhibit a circadian variation with peak levels in the morning, evidence-based guidelines recommend measuring morning total testosterone (TT) levels as the initial diagnostic test for androgen deficiency. However, it has been suggested that morning blood draw may not be necessary in older men due to a blunted circadian rhythm. We sought to determine whether it is possible to expand the morning sampling window for measurement of TT.

Research design and methods: TT levels were measured in a subset of men (mean age of 61 years) participating in the 2013 Prostate Cancer Awareness Week.

Results: TT levels measured in blood drawn from 8 to 11 AM (n = 229) differed significantly from those drawn outside this window (n = 442) (411.7 vs 368.3 ng/dl; p = 0.0003). Differences in TT levels were evident across five blood draw time windows (p = < 0.0001) and persisted after adjustment for age and BMI. TT levels in blood drawn from 2 to 5 PM (344.3 ng/dl) and 5 to 8 PM (334.4 ng/dl) differed significantly from that drawn from 8 to 11 AM (p < 0.05), while TT levels from 11 AM to 2 PM (396.5 ng/dl) and 8 PM to 8 AM (373.4 ng/dl) did not (p = 0.90 and 0.73, respectively). Conclusion: Based on these findings, it may be possible to expand the blood draw time window for measurement of serum TT. This community-based study was not prospectively design to determine the most appropriate blood draw window for TT measurement. Only a single TT measurement was made without consideration for day-to-day variability, and TT levels were not measured in the same men at different blood draw times.

Keywords: Blood sampling; Laboratory value; Methodology; Testosterone; Testosterone level.

Similar articles

Crawford ED, Poage W, Nyhuis A, Price DA, Dowsett SA, Muram D. Crawford ED, et al. Am J Mens Health. 2016 Sep;10(5):440-2. doi: 10.1177/1557988315590655. Epub 2015 Jun 14. Am J Mens Health. 2016. PMID: 26077271

Guay A, Miller MG, McWhirter CL. Guay A, et al. Int J Impot Res. 2008 Mar-Apr;20(2):162-7. doi: 10.1038/sj.ijir.3901580. Epub 2007 Jul 19. Int J Impot Res. 2008. PMID: 17637790

Smelser WW, Randall JH, Caldwell J, Glavin K, Lee EK, Nangia A, Holzbeierlein JM. Smelser WW, et al. Urol Oncol. 2021 Jul;39(7):435.e23-435.e31. doi: 10.1016/j.urolonc.2020.12.013. Epub 2021 Jan 1. Urol Oncol. 2021. PMID: 33397594 Clinical Trial.

Chueh KS, Huang SP, Lee YC, Wang CJ, Yeh HC, Li WM, Wu WJ, Tsai YF, Tsai CC, Juan HC, Huang CH, Liu CC. Chueh KS, et al. J Androl. 2012 Sep-Oct;33(5):817-23. doi: 10.2164/jandrol.111.015628. Epub 2012 Jan 12. J Androl. 2012. PMID: 22240559

Regis L, Planas J, Celma A, de Torres IM, Ferrer R, Morote J. Regis L, et al. Actas Urol Esp. 2015 Nov;39(9):573-81. doi: 10.1016/j.acuro.2015.03.004. Epub 2015 May 2. Actas Urol Esp. 2015. PMID: 25944770 Review. English, Spanish.

Cited by

Huang Z, Do DV, Beh D, Lee CK, Yan B, Foo R, Tambyah PA. Huang Z, et al. F S Sci. 2022 Feb;3(1):29-34. doi: 10.1016/j.xfss.2021.11.003. Epub 2021 Nov 20. F S Sci. 2022. PMID: 34841282 Free PMC article.

Pellikaan K, Ben Brahim Y, Rosenberg AGW, Davidse K, Poitou C, Coupaye M, Goldstone AP, Høybye C, Markovic TP, Grugni G, Crinò A, Caixàs A, Eldar-Geva T, Hirsch HJ, Gross-Tsur V, Butler MG, Miller JL, van den Berg SAA, van der Lely AJ, de Graaff LCG. Pellikaan K, et al. J Clin Med. 2021 Sep 24;10(19):4361. doi: 10.3390/jcm10194361. J Clin Med. 2021. PMID: 34640379 Free PMC article.

Publication types

Cheap Canadian Pharma LLC. 775 Cambie St, Vancouver, BC, Canada. All Rights Reserved.